Abstract
Embolotherapy using particle embolics is normally performed with exogenous contrast to assist in visualization. However, the exact location of the embolics cannot be identified after contrast washout. We developed a novel, pseudo-check valve-integrated microfluidic device, that partitions barium-impregnated alginate from crosslinking solution, thereby preventing nozzle failure. This enables rapid and continuous generation of inherently X-ray-visible embolic microspheres (XEMs) with uniform size. The XEMs are visible under clinical X-ray and cone beam CT both in vitro and in vivo. In particular, we demonstrated the embolization properties of these XEMs in large animals, performing direct intra-and post-procedural assessment of embolic delivery. The persistent radiopacity of these XEMs enables real-Time evaluation of embolization precision and offers great promise for non-invasive follow-up examination without exogenous contrast. We also demonstrated that bariatric arterial embolization with XEMs significantly suppresses weight gain in swine, as an example of a non-oncological application of embolotherapy. © The Royal Society of Chemistry 2020.
| Original language | English |
|---|---|
| Pages (from-to) | 3591-3600 |
| Journal | Lab on a Chip |
| Volume | 20 |
| Issue number | 19 |
| Online published | 1 Sept 2020 |
| DOIs | |
| Publication status | Published - 7 Oct 2020 |
| Externally published | Yes |
Funding
This work was supported by National Institutes of Health (NIH) R21/R33 HL089029 and R01 EB017615, American Heart Association (AHA) 16SDG30500010, and Maryland Stem Cell Research Fund 2011-MDSCRFII-0043. The authors thank Judy Mickey for assistance with the animal studies and Robert A Anders for histology evaluation.
Fingerprint
Dive into the research topics of 'Microfluidic-prepared, monodisperse, X-ray-visible, embolic microspheres for non-oncological embolization applications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver